A proposed intervention for newborn infants in countries with suspected vitamin A (VA) deficiency is to administer 50,000 IU retinyl palmitate at birth to reduce mortality risk. However, no studies have investigated birth weight effects. In this study, low birth weight (LBW; <1 kg, n ¼ 18) and healthy birth weight (HBW) piglets (>1.5 kg, n ¼ 18) from VA-depleted sows were dosed with 25,000 or 50,000 IU retinyl palmitate (26.2 or 52.4 mmol retinol equivalents) at birth to compare VA reserves. Blood was collected at varying times (n ¼ 3-5/time/dose), and piglets were killed at 12 or 24 h for blood, liver, kidneys, spleen, lungs, adrenal gland, and intestinal contents. HBW piglets had significantly higher birth, death, and organ weights than LBW (P < 0.0001 for all). HBW and LBW piglets, which received VA, had higher liver and kidney VA concentrations (0.18 AE 0.09, 0.24 AE 0.10 mmol/g liver and 13.4 AE 4.1, 14.2 AE 4.5 nmol/g kidney, respectively) than controls (n ¼ 10) (0.051 AE 0.01 mmol/g liver and 1.01 AE 0.43 nmol/g kidney) (P ¼ 0.0061 and < 0.0001, respectively). Total liver (9.75 AE 5.16 mmol) and kidney retinol (204 AE 79.1 nmol) were higher in HBW than LBW piglets (P < 0.0001). Extrahepatic tissues, except lung, had higher VA concentration than controls (P < 0.0001). Serum retinol and ester concentrations were higher in treated than control piglets (P ¼ 0.0028, P < 0.0001, respectively), and significantly changed during the times sampled (P ¼ 0.022, P ¼ 0.011, respectively). Peak serum retinyl ester concentrations, which occurred at 3 h, were higher in piglets that received 50,000 IU (4.2 AE 4.4 mmol/L) than 25,000 IU (2.7 AE 2.3 mmol/L) (P ¼ 0.031). Regardless of dose amount, HBW piglets stored more supplemental VA than LBW piglets when administered at birth.
Introduction
Birth weight is an anthropometric measurement that is used both clinically and globally as an indicator of newborn health. 1 Low birth weight (LBW) infants are classified as weighing <2.5 kg and the condition is usually caused by preterm birth (<37 weeks). 2 Factors that contribute to LBW include the nutritional status of the mother during pregnancy, such as young age, malnutrition, hypertension, smoking, drug or alcohol abuse, and insufficient prenatal care. 3 High prevalence of LBW, as well as birth defects, is common in developing countries, such as those in sub-Saharan Africa and Southeast Asia, which are the same regions that have a high prevalence of vitamin A (VA) deficiency. 3 LBW infants are often underdeveloped physiologically and have minimal VA stores, because of highly regulated trans-placental transport. 4 Preterm infants need VA for proper lung and retina development. 5 Extremely LBW infants (defined as birth weight <1 kg) often have low plasma and tissue concentrations of VA. 6, 7 Supplementation trials in LBW infants have yielded contraindicated results. Indeed, a VA supplementation study in Guinea-Bissau resulted in increased mortality of VA-supplemented LBW females, but no effect on males when dosed with 25,000 IU (25 kIU) (26.2 mmol retinol equivalents) retinyl palmitate. 8 However, 25 kIU was well-tolerated in both male and female South African LBW infants (42.9% males). 9 Recent studies show that maternal VA status is positively associated with birth weight, length, and head circumference. 10 In India, maternal night blindness increased the risk of LBW, 11 and maternal serum retinol concentrations <0.7 mmol/L were associated with preterm delivery. 12 However, research regarding maternal VA supplementation shows little evidence for efficacy in prevention of LBW or factors associated with VA D. A systematic review revealed that antenatal VA supplementation did not prevent LBW or preterm births. 13 In a randomized, placebo-controlled trial in Bangladesh, 10 weekly VA or b-carotene supplementation to mothers during pregnancy until three months post-partum did not reduce the overall incidence of preterm birth or fetal growth restriction that contribute to LBW. Further, birth weights of infants whose mothers had received the supplements were not different from those whose mothers had received the placebo. 10 Historically, VA deficiency has been treated by government-regulated supplementation with preformed VA. The World Health Organization (WHO) recommends preformed VA supplements to infants and young children in areas of high VA deficiency prevalence, but there is no dosing recommendation regarding birth weight. WHO currently recommends that children 6-11 months old receive a one-time dose of 100,000 IU VA and that those 12-59 months old receive 200,000 IU VA every 4-6 months to mitigate mortality risk. 14 Previously, WHO recommended that infants receive 50,000 IU (50 kIU) VA (52.4 mmol retinol equivalents) at immunization contacts at age 6, 10, and 14 week, 15 but it is no longer recommended that children under six months receive supplementation based on little or no impact on childhood mortality rates. 16 A proposal to orally administer 50 kIU VA at birth is currently undergoing population and mechanistic evaluation.
Although VA status of infants can be determined by dose response or stable isotope tests, 17 studies that determine organ uptake of newly ingested VA are not feasible in LBW human infants due to lack of appropriate methodology. Piglets are an appropriate model due to similar physiology and size, compared with rodent models. Thus, LBW and healthy birth weight (HBW) piglets from VA-depleted sows were orally dosed with 25 kIU or 50 kIU VA and killed 12 or 24 h after dosage to evaluate VA distribution to various tissues. These VA doses were chosen based on previous evidence that 25 kIU was welltolerated and 50 kIU was a previous recommendation by WHO for infants <6 months. We hypothesized that HBW piglets would absorb more VA than LBW, due to more mature gastrointestinal and organ development.
Materials and methods

Animal care and dosing
Approval was obtained from the University of Wisconsin-Madison Animal Care and Use Committee and included a recommendation that not all blood samples be obtained from the same piglets within the 24-h period of the study. Sows (n ¼ 11; Sus scrofas domesticas, crossbreeds of Large White and Landrace) were housed at the Swine Research and Teaching Center (Arlington, WI). The sows had 3.3 AE 2.7 (mean AE SD) overall parities and one prior VA-depleted parity before entering the study. Sows were fed a VA-free wheat diet throughout gestation and lactation. 18 Male and female piglets (n ¼ 36) meeting study criteria (<1.0 kg or >1.5 kg) were paired from the same sow and randomly dosed orally with 25 kIU or 50 kIU retinyl palmitate (26.2 or 52.4 mmol retinol equivalents) at $12-h post farrowing. The dose was supplied by WHO as 50 kIU ''cut and squeeze'' softgel capsules (retinyl palmitate, Strides Acrolab, India). The 25 kIU doses were diluted with soybean oil to administer approximately the same volume of oil as the 50 kIU group. Doses (200 mL) were administered orally with a positive displacement pipet, which was placed deep into the piglets' throats before discharge. Blood was collected at 1.5 and 5 h for piglets killed at 12 h, and 3 and 7 h for 24-h kill piglets. A group of control piglets (n ¼ 10), weighing >1.0 and <1.5 kg were dosed with 250 mL soybean oil and killed at 24 h. Liver, lungs, kidney, adrenal gland, spleen, and blood were collected from all piglets after killing. Intestinal contents were collected by saline wash on a subset of piglets (n ¼ 20) from a 10-cm section of the intestine, which was 10 cm distal from the pyloris.
Piglet tissue analysis
Liver 19 and serum 20 were analyzed using published methods. Kidney was analyzed using an adaptation of published methods. 21 Kidney (0.5 g) was ground with sodium sulfate (3-4 g) in a mortar, and C-23 b-apo-carotenol was added to determine extraction efficiency. Dichloromethane was used to extract retinol and retinyl esters and filtered into a 25-mL volumetric flask; 5 mL was dried under nitrogen and dissolved in 100 mL 50 : 50 (v : v) methanol:dichloromethane; 20 mL was injected. The HPLC system included a Resolve C 18 (5 mm, 3.9 Â 300 mm) reverse-phase column, Waters 600 binary pump (Milford, MA), Shimadzu Chromatopac C-R7A plus and SPD-10 AVP UV-Vis detector (Kyoto, Japan). Solvent and runtime were as described. 20 Lung (5 g), adrenal gland (0.5 g), and spleen (2 g) were run using an adaptation to published methods. 21 The samples were extracted three times with 20 mL (lung) or 10 mL (adrenal and spleen) dichloromethane. The extract was dried in a round-bottom flask using a rotary evaporator. The residue was redissolved in dichloromethane three times (2, 1, and 1 mL) and transferred to a glass tube (13 Â 100 mm). The combined solution was dried under nitrogen and redissolved in 100 mL 50:50 (v:v) methanol:dichloromethane; 50 mL was injected onto a Waters HPLC system with a 2707 autosampler, 1525 binary pump, and 2996 photodiode array detector (Milford, MA). Solvent A consisted of 92.5:7.5 (v:v) acetonitrile:water and solvent B consisted of 85:10:5 (v:v) acetonitrile:methanol:dichloroethane (10 mmol/L ammonium acetate in each solvent).
Intestinal contents (0.5 mL) were added to 0.5 mL ethanol with 0.1% butylated hydroxytoluene as an antioxidant. C23b-apo-carotenol (200 mL) was added as an internal standard, mixed with a vortex, and centrifuged. The sample was extracted three times with 1 mL hexanes. Organic layers were pooled, dried under nitrogen, and resuspended in 200 mL 50:50 (v:v) methanol:dichloroethane; 25 mL was injected onto a Waters C-18 3 -mm, 3.9 Â 300-mm reversedphase column (Milford, MA) equipped with a guard column. Solvent A consisted of 92.5:7.5 (v:v) acetonitrile:water (10 mmol/L ammonium acetate) and solvent B consisted of 80:10:10 (v:v) acetonitrile:methanol:dichloroethane. The HPLC system and specifications were the same as described for lung.
Quantification
Retinol and retinyl esters (e.g. linoleate, oleate, palmitate, and stearate) in all tissues were identified by comparing their retention times with synthesized or isolated standards, as well as characteristic spectra, and quantified using retinol and retinyl butyrate, respectively, based on the E 1% 1 cm of retinol (i.e. 1845 in alcohol). Both retinol concentration and total retinol reserves in each tissue collected were calculated. All VA values in tissues were calculated based on tissue wet weight. The percent retention of VA dose in piglet tissues for treatment groups was calculated: total amount of retinol in the treatment group minus the control, divided by the ingested VA amount.
Statistical analysis
SAS software (version 9.2, Cary, NC) was used. Values are presented as means AE SD. ANOVA was used to test differences. Levene's test for homogeneity was used to determine unequal variances. Repeated measure tests were applied to organ data sets with unequal variances. Three-way ANOVA was used to evaluate the effect of the VA dose according to dose amount, birth weight, and time. To account for the inter-piglet variation in the serum retinol concentrations, the peak value for each piglet was assigned a value of 1 and other times for the same piglet were normalized as a fraction of the peak and these values were further used in the statistical evaluation of the data. P 0.05 was considered significant and interactions with P < 0.1 were considered important.
Results
Birth and final weights
By design, LBW piglets weighed 0.93 AE 0.06 kg and HBW piglets weighed 1.79 AE 0.29 kg at birth (P < 0.0001). Control piglets weighed 1.30 AE 0.19 kg and their weight was significantly different from both LBW and HBW (P < 0.0001). There was no difference between birth and final weights of the piglets from the VA treatment groups; however, piglets were significantly heavier in 24-h kill groups for both birth and final weights than the 12-h kill groups (P ¼ 0.044 and 0.035, respectively). All organs collected were significantly heavier in HBW piglets than LBW piglets ( Table 1 , P < 0.0001).
Liver retinol
Retinol includes the sum of the free form and all identifiable retinyl esters. Overall, both HBW and LBW piglets' liver retinol concentrations were significantly higher than control piglets that received no dose (Figure 1a , P < 0.0001). Piglets had higher liver concentration at 24 h than at 12 h (P ¼ 0.036). However, no significant differences occurred between dose, weight, or time groups. All dosed piglets were above the VA deficiency cutoff of 0.07 mmol/g and 34 (94.4%) were above 0.1 mmol/g liver, a biologically relevant cutoff, 17 but the control piglets were all VA-deficient. Correcting for organ weight, total liver retinol ( Figure 1b ) in both HBW and LBW piglets was significantly higher than the controls (P < 0.0001). HBW piglets had significantly higher total liver retinol (9.75 AE 5.16 mmol) compared with LBW piglets (4.91 AE 2.01 mmol) (P ¼ 0.0002). All piglets killed at 24 h had significantly higher total liver retinol (9.33 AE 5.30 mmol) than those killed at 12 h (5.43 AE 2.64 mmol) (P ¼ 0.0015), likely due to the impact of a subsequent meal. A trend existed for an interaction between dose amount and time (P ¼ 0.087), indicating that both the dose level and the sampling time influenced the total amount recovered in the liver.
Extrahepatic tissues
All piglets treated with VA had significantly higher kidney retinol concentration and total kidney retinol than control piglets, which did not receive VA ( Table 2 , P < 0.0001). There were no differences in retinol concentration among dose, time, or weight groups. HBW piglets had significantly higher total kidney retinol (203.8 AE 79.1 nmol) than LBW piglets (114.8 AE 34.0 nmol) (P ¼ 0.0002). Spleen retinol concentration and total retinol were significantly higher in VA-treated piglets (2.82 AE 2.28 nmol/g, 4.93 AE 4.69 nmol/spleen, respectively) than controls that did not receive VA (0.60 AE 0.29 nmol/g, 1.56 AE 0.66 nmol/spleen, respectively) ( Table 2 , P < 0.0001, P ¼ 0.0017, respectively). Birth weight was important (P ¼ 0.055), and an interaction between birth weight and time sampled may have influenced spleen retinol concentration and total uptake (P ¼ 0.086).
Lung VA concentration and total lung VA did not differ among dose, time, or weight groups of the VAsupplemented piglets at the times of kill but there was a trend for total VA in HBW piglets to be higher ( Table 2 , P ¼ 0.076).
Adrenal gland VA was higher in treated piglets than controls for both VA concentration and total VA ( Table 2 , P < 0.0001, P ¼ 0.018, respectively). Dose level and time did not affect adrenal gland VA concentration. A trend for a difference in LBW piglets having higher VA concentration than HBW piglets existed (P ¼ 0.066).
Serum retinol and retinyl esters
VA-treated piglets had significantly higher serum retinol and retinyl ester concentrations than control piglets (Figure 2 ; P ¼ 0.011, P < 0.0001, respectively). Piglets dosed with 50 kIU had significantly higher serum retinyl esters (3.79 AE 3.85 mmol/L) than those dosed with 25 kIU (2.53 AE 2.24 mmol/L) (P ¼ 0.05), but serum retinol concentrations were not different between the two dose groups. Time was a significant factor for both serum retinol and retinyl esters (P ¼ 0.022 and P ¼ 0.017, respectively). Serum retinol concentrations at 1.5, 3, 5, 7, 12, and 24 h were 1. 15 (Figure 2b ). Weight status did not influence serum retinol or retinyl ester concentration response to VA treatment.
Percentage of dose
Although the entire intestinal contents were not collected, 0.03-17% of the administered dose was recovered from the intestinal lumen at tissue harvest. The highest percentage of VA-dose retention was found in the liver. The percentage of dose stored in liver for the 25 kIU and 50 kIU groups did not differ at 24 h (Table 3 ). HBW piglets stored a higher percentage of administered VA than LBW piglets (P ¼ 0.0006), and this represented approximately 200% more dose stored in the HBW piglets than in the LBW piglets ( Table 3 ). All piglets had higher retinyl ester accrual at 24 h than 12 h (P ¼ 0.0097), which likely represents some of the dose being retained in the intestinal wall awaiting new chylomicron formation with subsequent meals. There was no difference in percent storage of VA dose between piglets dosed with 25 kIU or 50 kIU, but an interaction between dose level and time existed (P ¼ 0.014) and a trend for an interaction with dose, time, and weight existed (P ¼ 0.064).
Discussion
Currently, the only evidence-based WHO recommendation for VA supplementation is for 12-to 59-month-old children to receive 200,000 IU retinyl palmitate every 4-6 months and those who are 6-11 mo to receive one 100,000 IU dose. 14 Although a proposal to give 50 kIU VA as retinyl palmitate to newborn infants is undergoing evaluation, there are no guidelines regarding birth weight. This study compared 25 kIU and 50 kIU VA supplements between LBW and HBW piglets born to VA-depleted sows. Newborn infant dosing regimens were explored because a study in Indonesia documented a remarkable 0.36 relative risk in infant mortality for those infants who received 50 kIU VA at birth compared with a placebo. 22 A study with LBW infants administered 25 kIU VA found that the dose was well-absorbed and no adverse effects were noted. 23 Our study found that both the 25 kIU and 50 kIU doses were efficacious because all organs from HBW and LBW piglets, except lung at the times sampled, were higher in piglets receiving the VA dose than control piglets receiving no VA. However, it must be noted that no difference was detected between the 25 kIU and 50 kIU doses in any of the tissues sampled likely indicating a threshold for VA uptake and storage. Some studies have used the sow-piglet model to investigate VA supplementation and storage in liver, but few have investigated the storage of VA in extrahepatic tissues post-supplementation. Vitamin A is crucial for both preand post-natal lung development and is stored primarily as retinyl esters. [24] [25] [26] Lung and kidney retained <1% of the doses administered in this study and thus likely do not represent major storage sites for drawing on long-term VA needs of high-dose supplements given at birth. The low retention in the lung confirms prior studies in rats. 25, 27 Supplementing rats with retinyl palmitate alone did not increase fractional uptake of 3 H-VA in lung, but uptake was increased with co-treatment of acidic retinoids. 27 The highest retention in the liver found in the HBW piglets at 24 h (i.e. 37.4%) was similar to neonatal rats ($40%). 27 The rank of VA concentration in organs analyzed was liver > kidney > adrenal glands > spleen > lung for all treated piglets within one day after dosage. The rank of spleen and lung differed from piglets killed 10 days after supplementation, 21 where lung had a higher retinol concentration than spleen. The higher spleen concentration at one day in the current study is likely due to the scavenging of chylomicra after the large doses given in this study. 28 In a prior swine study, 21 spleen acquired more chylomicron-derived 3,4-didehydroretinol in a 4-h timeframe than the lung. The retinol values from the high doses of VA would have had more time to equalize with total body retinol in the Sun et al. study considering the 10-day wait period before organ harvest. 21 Further, lung retinol concentrations likely peaked earlier than 12 h in the current study considering that the first pass of chylomicron-delivered VA, which deliver large amounts to the lung, 19, 21, 29 would have cleared before 12 h.
Both VA deficiency and LBW prevalence are high in developing countries, due in part to widespread maternal malnutrition. 30 The condition of LBW is usually the result of the infant being born preterm (before 37 weeks). These infants have increased susceptibility to morphalities of the eye, respiratory system, and gastrointestinal tract. 5 VA deficiency is problematic in newborn LBW infants who have an underdeveloped respiratory tract, which increases their susceptibility for infection. Lack of VA transfer to the fetus from mothers with low VA status further impairs growth and development of LBW infants. 31 In a study with South African LBW infants, there were no differences in respiratory disease development within the first year of life between LBW infants given three 25 kIU VA doses and those given placebos within eight days of life. 9 In addition, LBW and very LBW prevalence is influenced by risk of disease and lack of prenatal care in some developing countries. 30 Healthy newborn infants from VA-sufficient mothers are already born with limited VA stores due to tight regulation of placental transfer, 4 thus it is not surprising that LBW infants born to mothers who are VA-deficient are compromised. Even in breastfed infants, preterm infants were found to have significantly lower plasma retinol concentrations than term infants at four weeks of age. 32 LBW, small-for-gestational age, and preterm birth are associated with increased odds of wasting, stunting, and underweight, 33 which may negatively impact gut health. Abnormal morphology and delayed development of the small intestine may impact VA absorption. Preterm infants have abnormal intestinal morphology and decreased mucosal DNA, as well as decreased protein content and enzymatic activity. 34 A rat study found that inducing VA deficiency in late pregnancy resulted in less growth of intestinal villi in the small intestine of fetuses. 35 The difference in liver retinol storage between LBW and HBW piglets may be due to length of the absorptive intestinal tract or stellate cell development. Little is known about the specific development of stellate cells, other than that their production arises from mesenchymal stem cells. 36 LBW infants are often given perinatal nutrition or special formulas, rather than breast milk from their mothers. 30 In this study, piglets were not given any additional supplements other than the VA dose $12 h after birth. LBW and HBW piglets relied on their VA-depleted mother for milk throughout the study, which could not be equalized. It was not feasible to measure milk consumption; therefore, a combination of diminished intestinal development and possibly lower milk intake by the LBW piglets could have contributed to variance in this study.
The intestinal contents were collected to provide a snapshot of unabsorbed VA dose during the study. VA doses are more efficacious when given as a lipid bolus, in addition to that which is delivered in milk. 37 However, young infants may not be able to absorb these doses as efficiently as older children, 38 and very LBW infants need special nutritional management. 37 The percentage of dose found in extrahepatic organs did not differ between treatment or time groups, similar to VA concentration. The higher recovery in the piglets that were killed at 24 vs. 12 h likely reflects more uptake of the VA dose during subsequent meals. Considering unabsorbed dose was detected in the intestinal contents, absorbed retinol was likely still present in the intestinal cells waiting for another meal to be esterified and packaged into new chylomicra for circulation and storage. 20, 39, 40 Fat from a previous meal contributes to early chylomicra release from the intestine. 39 Fat-soluble vitamins are also retained when high doses are administered.
Serum retinol concentrations did not follow any obvious pattern. This could be because the piglets were not the same at each time point and normalization of the data mitigated any statistical findings of these data. On the other hand, retinyl esters peaked by 7 h and there was a treatment effect such that the 50 kIU dose resulted in a higher peak retinyl ester concentration than the 25 kIU dose. However, this did not result in greater accrual of VA in all analyzed organs. Birth weight had an overall greater effect on outcomes in this study than dose level.
VA deficiency and LBW continue to be problems in many countries. While certain factors increase the risk and prevalence of LBW, it is difficult to plan LBW status For liver, percentage of dose retained was significantly higher at 24 h than 12 h (P ¼ 0.01). c For liver, percentage of dose retained was higher in HBW piglets than LBW (P ¼ 0.0006); an interaction between treatment Â time existed (P ¼ 0.037), and a trend occurred for treatment Â time Â weight (P ¼ 0.064). d A trend existed for lung to have a higher percentage of dose retained by treatment (P ¼ 0.074) and birth weight (P ¼ 0.08). No significant differences occurred for adrenal gland. e For kidney, the percentage of dose retained was higher in 25 kIU-dosed piglets than 50 kIU-dosed piglets (P ¼ 0.002). f For kidney, the percentage of dose retained was higher in HBW piglets than LBW piglets (P ¼ 0.001).
into prospective studies. In this newborn piglet model, serum retinol and retinyl ester concentrations combined with percentage of dose stored described the destination and distribution of newly administered VA supplementation. Birth weight affected VA absorption, distribution, and liver storage in newborn piglets, and this finding should be taken into account when determining a regimen for newborn infants.
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